<?xml version="1.0" encoding="UTF-8"?>
<ref id="bb0255">
 <label>51</label>
 <element-citation publication-type="journal" id="rf0250">
  <person-group person-group-type="author">
   <name>
    <surname>Lacaille</surname>
    <given-names>D.</given-names>
   </name>
   <name>
    <surname>Guh</surname>
    <given-names>D.P.</given-names>
   </name>
   <name>
    <surname>Abrahamowicz</surname>
    <given-names>M.</given-names>
   </name>
   <name>
    <surname>Anis</surname>
    <given-names>A.H.</given-names>
   </name>
   <name>
    <surname>Esdaile</surname>
    <given-names>J.M.</given-names>
   </name>
  </person-group>
  <article-title>Use of nonbiologic disease-modifying antirheumatic drugs and risk of infection in patients with rheumatoid arthritis</article-title>
  <source>Arthritis Rheum</source>
  <volume>59</volume>
  <year>2008</year>
  <fpage>1074</fpage>
  <lpage>1081</lpage>
  <pub-id pub-id-type="doi">10.1002/art.23913</pub-id>
  <pub-id pub-id-type="pmid">18668604</pub-id>
 </element-citation>
</ref>
